A study from the Duke Department of Pharmacology and Cancer Biology reveals why higher levels of testosterone cause early prostate cancers to grow but can stop later-stage disease. The findings promise to help doctors better target treatment.

NIH Method to Extend Research in Time (MERIT) Award supports research of the immune evasion strategies of Chlamydia trachomatis, the most common sexually transmitted bacterial infection.

By analyzing their spike proteins, Duke researchers reveal how the Omicron XBB variants balance stability, receptor usage and immune evasion.

Debra Silver, PhD, professor of molecular genetics and microbiology, cell biology and neurobiology at Duke University School

The Duke Human Vaccine Institute has received funding from the National Institutes of Health to manufacture H5N1 avian flu vaccines for use in clinical trials.

A Duke study found that wearable, long-term continuous heart monitors helped identify more cases of atrial fibrillation but did not lead to a reduction in hospitalizations due to stroke.

Over her 35 years in the Department of Psychiatry & Behavioral Sciences, Jeannie Beckham, PhD, has mentored more than 140 undergraduates, graduate students, clinical psychology trainees, postdoctoral fellows, and junior faculty members.

In 2023 the global temperature climbed to the highest on record since the industrial revolution, and in the United States, heat-related deaths doubled between 1999 and 2023. Adverse effects of climate change often amplify risk for the most vulnerable groups, including the elderly, those with low incomes, and mothers and children.

In a study published earlier this month in the journal Pediatrics Research, researchers in the Duke Department of Psychiatry and Behavioral Sciences documented the complexity of emotional dysregulation in pregnant women and showed that it is linked to neurobehavior in their newborns.

Christine Eyler is exploring how tumors evolve during treatment to identify vulnerabilities that could lead to more effective cancer therapies. By studying rectal cancer organoids and epigenetic changes, Eyler aims to uncover new strategies that could eventually translate into personalized treatments for patients.